44408 Federal Register / Vol. 62, No. 162 / Thursday, August 21, 1997 / Rules and Regulations

in February 1997, and a check of the aircraft

records will give a good indication as to

whether these filters have been installed on

an aircraft.

(c) Special flight permits may be issued for

daytime visual flight rules (VFR) flight only,

in accordance with sections 21.197 and

21.199 of the Federal Aviation Regulations

(14 CFR 21.197 and 21.199) to operate the

airplane to a location to accomplish the

requirement of this AD.

(d) An alternative method of compliance or

adjustment of the compliance time that

provides an equivalent level of safety may be

approved by the Manager, Chicago Aircraft

Certification Office, 2300 E. Devon, Des

Plaines, Illinois 60018. The request shall be

forwarded through an appropriate FAA

Maintenance Inspector, who may concur or

comment and then send it to the Manager,

Chicago Aircraft Certification Office.

Note 4: Information concerning the

existence of approved alternative methods of

compliance with this AD, if any, may be

obtained from the Chicago Aircraft

Certification Office.

(e) Information related to this AD may be

inspected at the FAA, Central Region, Office

of the Assistant Chief Counsel, Room 1558,

601 E. 12th Street, Kansas City, Missouri

64106.

(f) This amendment (39–10103) becomes

effective on September 18, 1997, to all

persons except those persons to whom it was

made immediately effective by priority letter

AD 97–16–10, issued July 31, 1997, which

contained the requirements of this

amendment.

Issued in Kansas City, Missouri, on August

14, 1997.

Michael Gallagher,

Manager, Small Airplane Directorate, Aircraft

Certification Service.

[FR Doc. 97–22147 Filed 8–20–97; 8:45 am]

BILLING CODE 4910–13–U

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Parts 121, 125, 129, and 135

[Docket No. 28109; Amendment Nos. 121–

266, 125–30, 129–27, 135–69]

RIN 2120–AF76

Revisions to Digital Flight Data

Recorder Rules

AGENCY: Federal Aviation

Administration, DOT.

ACTION: Final rule; correction.

Correction

In rule document 97–18514 beginning

on page 38362 in the issue of Thursday,

July 17, 1997, make the following

correction:

FOR FURTHER INFORMATION CONTACT:

[Corrected]

1. On page 38362, in the first column,

under FOR FURTHER INFORMATION

CONTACT: in the sixth line, the telephone

number ‘‘(202) 267–8096’’ should read

‘‘(202) 267–8166’’.

Issued in Washington, DC, on August 15,

1997.

Brenda D. Courtney,

Manager, Aircraft and Airports Rules

Division.

[FR Doc. 97–22262 Filed 8–20–97; 8:45 am]

BILLING CODE 4910–13–M

RAILROAD RETIREMENT BOARD

20 CFR Part 335

RIN 3220–AB30

Sickness Benefits

AGENCY: Railroad Retirement Board.

ACTION: Final rule.

SUMMARY: The Railroad Retirement

Board (Board) hereby amends its

regulations under the Railroad

Unemployment Insurance Act (RUIA) to

permit a substance-abuse professional to

execute a statement of sickness in

support of payment of sickness benefits

under the RUIA.

EFFECTIVE DATE: This rule will be

effective September 22, 1997.

ADDRESSES: Secretary to the Board,

Railroad Retirement Board, 844 North

Rush Street, Chicago, Illinois 60611.

FOR FURTHER INFORMATION CONTACT:

Thomas W. Sadler, Senior Attorney,

Railroad Retirement Board, 844 North

Rush Street, Chicago, Illinois 60611,

(312) 751–4513, TDD (312) 751–4701.

SUPPLEMENTARY INFORMATION: Section

335.2(a)(2) of the Board’s regulations

provides that in order to be entitled to

sickness benefits under the RUIA, a

claimant must provide a ‘‘statement of

sickness.’’ Section 335.3(a) of the

Board’s regulations lists the individuals

from whom the Board will accept a

statement of sickness. That list does not

currently include a ‘‘substance-abuse

professional’’ (SAP), although

employees may claim sickness benefits

under circumstances resulting from

alcohol or controlled-substances-related

disorders. In providing that an SAP

under this part must meet the

qualifications outlined in the

Department of Transportation (DOT)

regulations at 49 CFR part 40.3, the

Board recognizes the importance of

nationally-accepted standards for SAPs.

The DOT regulations define an SAP as

a licensed physician (Medical Doctor or

Doctor of Osteopathy), a licensed or

certified psychologist, a licensed or

certified social worker, or a licensed or

certified employee assistance

professional. The DOT regulations also

include alcohol and drug abuse

counselors certified by the National

Association of Alcoholism and Drug

Abuse Counselors (NAADAC)

Certification Commission, a national

organization imposing qualification

standards for treatment of alcohol and

drug-related disorders.

Under the DOT regulations, an SAP

must have knowledge of, and clinical

experience in, the diagnosis and

treatment of alcohol and controlled

substances-related disorders.

Accordingly, those individuals who

have the requisite degrees or certificates,

but who lack knowledge and clinical

experience in alcohol and substance

abuse-related disorders, would not meet

the criteria of a qualified SAP under this

part.

The Board published this rule as a

proposed rule on April 18, 1997 (62 FR

19072), and invited comments by June

17, 1997. No comments were received.

The Board, with the concurrence of

the Office of Management and Budget,

has determined that this is not a

significant regulation action for

purposes of Executive Order 12866.

Therefore, no regulatory impact analysis

is required. There are no information

collections associated with this rule.

List of Subjects in 20 CFR Part 335

Railroad employees, Railroad sickness

benefits.

For the reasons set out in the

preamble, title 20, chapter II, part 335 of

the Code of Federal Regulations is

amended as follows:

PART 335—SICKNESS BENEFITS

1. The authority citation for part 335

continues to read as follows:

Authority: 45 U.S.C. 362(i) and 362(l).

2. Section 335.3(a) is amended by

removing ‘‘or’’ at the end of paragraph

(a)(8) of this section, by removing the

period at the end of paragraph (a)(9) of

this section and adding ‘‘; or’’, and by

adding a new paragraph (a)(10) to read

as follows:

§ 335.3 Execution of statement of sickness

and supplemental doctor’s statement.

(a) * * *

(10) A substance-abuse professional as

defined in 49 CFR part 40.3, if the

infirmity involves alcohol or controlled

substances-related disorders.

* * * * *

Dated: August 12, 1997.

By Authority of the Board.
Federal Register / Vol. 62, No. 162 / Thursday, August 21, 1997 / Rules and Regulations 44409

For the Board.

Beatrice Ezerski,

Secretary to the Board.

[FR Doc. 97–22131 Filed 8–20–97; 8:45 am]

BILLING CODE 7905–01–P–M

RAILROAD RETIREMENT BOARD

20 CFR Part 367

RIN 3220–AB26

Collection of Debts

AGENCY: Railroad Retirement Board.

ACTION: Final rule.

SUMMARY: The Railroad Retirement

Board (Board) amends its regulations

pertaining to the collection of debts by

offset against Federal payments to

reflect amendments to section 3716 of

Title 31 by the Debt Collection

Improvement Act of 1996 (Pub. L. 104–

134).

DATES: Effective Date: This Regulation

will be effective August 21, 1997.

ADDRESSES: Secretary to the Board,

Railroad Retirement Board, 844 North

Rush Street, Chicago, Illinois 60611.

FOR FURTHER INFORMATION CONTACT:

Michael C. Litt, General Attorney,

Bureau of Law, Railroad Retirement

Board, 844 North Rush Street, Chicago,

Illinois 60611, (312) 751–4929, TDD

(312) 751–4701.

SUPPLEMENTARY INFORMATION: Part 367 of

the Board’s regulations provides for the

collection of debts by administrative

offset under the authority of the Debt

Collection Act of 1982, 31 U.S.C. 3716.

The Debt Collection Improvement Act of

1996 (Pub. L. 104–134) amended 31

U.S.C. 3716 to provide for referral of

delinquent Federal nontax debts to the

Department of Treasury for

administrative offset (‘‘Treasury Offset

Program’’), and to provide for the

mandatory referral of such debts over

180 days delinquent to the Treasury

Offset Program, subject to certain

exceptions. Accordingly, the Board

amends this part to implement the

provisions of Public Law 104–134.

Section 367.1 is revised to cite the

authority of Public Law 104–134 and its

provision for the referral of delinquent

Federal nontax debts to the Treasury

Offset Program.

Section 367.2 is amended to provide

that only nontax debts will be referred

to the Treasury Offset Program, and that

a debt will not be referred if the Board’s

records show that foreclosure is pending

on collateral securing the debt or if the

debt has been referred to the

Department of Justice or is otherwise in

litigation with the Board.

Section 367.3 is amended to provide

that the Board shall refer nontax debts

over 10 days delinquent to the Treasury

Offset Program and that in cases of

mandatory referral of delinquent debt,

unless otherwise directed by the

Secretary of Treasury, the Board is not

required to determine whether

administrative offset is feasible,

allowable, and appropriate.

The Board, with the concurrence of

the Office of Management and Budget,

has determined that this is not a

significant regulatory action under

Executive Order 12866. Therefore, no

regulatory impact analysis is required.

There are no new information

collections associated with this rule.

The Board published this rule as an

interim final rule on April 21, 1997 (62

FR 19219) and comments were invited

by June 20, 1997. No Comments were

received. Accordingly, the interim final

rule is adopted as a final rule without

change.

Dated: August 12, 1997.

By Authority of the Board.

For the Board.

Beatrice Ezerski,

Secretary to the Board.

[FR Doc. 97–22130 Filed 8–20–97; 8:45 am]

BILLING CODE 7905–01–P–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522

Implantation or Injectable Dosage

Form New Animal Drugs; Doramectin

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect

approval of a supplemental new animal

drug application (NADA) filed by Pfizer,

Inc. The supplemental NADA provides

for use of doramectin in cattle to control

infections and to protect from

reinfection with Cooperia punctata and

Dictyocaulus viviparus for 28 days after

treatment. This supplemental NADA

also amends the wording of the claim

for protection against infection or

reinfection with Ostertagia ostertagi for

21 days and incorporates the claim into

the new indication statement.

EFFECTIVE DATE: August 21, 1997.

FOR FURTHER INFORMATION CONTACT:

Thomas Letonja, Center for Veterinary

Medicine (HFV–135), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1643.

SUPPLEMENTARY INFORMATION: Pfizer,

Inc., 235 East 42d St., New York, NY

10017–5755, is sponsor of NADA 141–

061 that provides for the use of

Dectomax 1% injectable solution

(doramectin) for treatment and control

of certain gastrointestinal roundworms,

lungworms, eyeworms, grubs, lice, and

mange mites of cattle, and protection

against infection or reinfection with O.

ostertagi for up to 21 days. The firm

filed a supplemental NADA that

provides for added use in cattle to

control infections and to protect from

reinfection with C. punctata and D.

viviparus for 28 days after treatment.

The supplemental NADA also amends

the wording of the claim for ‘‘* * *

protection against infection or

reinfection with Ostertagia ostertagi for

21 days’’ and incorporates the claim

into the new indication statement. The

supplemental NADA is approved as of

July 18, 1997, and the regulations are

amended in 21 CFR 522.770(d)(2) to

reflect the approval. The basis of

approval is discussed in the freedom of

information summary.

In accordance with the freedom of

information provisions of 21 CFR part

20 and 514.11(e)(2)(ii), a summary of

data and information submitted to

support approval of this application

may be seen in the Dockets Management

Branch (HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857, from 9

a.m. to 4 p.m., Monday through Friday.

Under section 512(c)(2)(F)(iii) of the

Federal Food, Drug, and Cosmetic Act,

this supplemental approval for foodproducing animals qualifies for 3 years

of marketing exclusivity beginning July

18, 1997, because the supplement

contains substantial evidence of the

effectiveness of the drug involved,

studies of animal safety or, in the case

of food-producing animals, human food

safety studies (other than

bioequivalence or residue studies)

required for approval of the supplement

and conducted or sponsored by the

applicant. Exclusivity applies only to

the added indication to control

infections and to protect cattle from

reinfection with C. punctata and D.

viviparus for 28 days after treatment.

The agency has determined under 21

CFR 25.24(d)(1)(i) that this action is of

a type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.